nach oben

Erschienen in:

01.09.2007 | Research Paper

Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma

verfasst von: Mikio Terauchi, Hiroaki Kajiyama, Mamoru Yamashita, Mikihiko Kato, Hirohisa Tsukamoto, Tomokazu Umezu, Satoyo Hosono, Eiko Yamamoto, Kiyosumi Shibata, Kazuhiko Ino, Akihiro Nawa, Tetsuro Nagasaka, Fumitaka Kikkawa

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Loss of E-cadherin triggers peritoneal dissemination, leading to an adverse prognosis for most patients with epithelial ovarian carcinoma (EOC). Because TWIST mainly regulates the epithelial-to-mesenchymal transition and is one of the E-cadherin repressors, we investigated the possibility that TWIST expression affects peritoneal metastasis of EOC using siRNA technique. In the present study, we showed a correlation between TWIST expression and EOC cellular morphology. Furthermore, we demonstrated that the suppression of TWIST expression in EOC cells (HEY) alters the cellular morphology from a fibroblastic and motile phenotype to an epithelial phenotype, and inhibits the adhesion of these cells to mesothelial monolayers. To investigate the mechanism by which down-regulation of TWIST leads to inhibition of adhesion to mesothelial cells (MCs), expression of adhesion molecules (CD29, CD44 and CD54) were observed. Moreover, matrix metalloproteinase 2 and membrane type 1 matrix metalloproteinase, important markers associated with invasive and metastatic potential, were remarkably reduced. This findings suggests that reduced expression of TWIST suppresses the multistep process of peritoneal dissemination (detachment from the primary lesion, adhesion to MCs and invasion of MCs) and may be a potential therapeutic target for the treatment of this carcinoma.

Pisani P, Parkin DM, Bray F et al (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:870–873PubMedCrossRef

Naora H, Montell DJ (2005) Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 5:355–366PubMedCrossRef

Kikkawa F, Matsuzawa K, Arii Y et al (2000) Randomized trial of cisplatin and carboplatin versus cisplatin, vinblastine and bleomycin in ovarian cancer. Gynecol Obstet Invest 50:269–274PubMedCrossRef

Conacci-Sorrell M, Zhurinsky J, Ben-Ze’ev A et al (2002) The cadherin–catenin adhesion system in signaling and cancer. J Clin Invest 109:987–991PubMedCrossRef

Takeichi M (1993) Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5:806–811PubMedCrossRef

Varner JA, Cheresh DA (1996) Integrins and cancer. Curr Opin Cell Biol 8:724–730PubMedCrossRef

Ruoslahti E (1999) Fibronectin and its integrin receptors in cancer. Adv Cancer Res 76:1–20PubMedCrossRef

Orr FW, Wang HH, Lafrenie RM et al (2000) Interactions between cancer cells and the endothelium in metastasis. J Pathol 190:310–329PubMedCrossRef

Holly SP, Larson MK, Parise LV et al (2000) Multiple roles of integrins in cell motility. Exp Cell Res 261:69–74PubMedCrossRef

10.

Felding-Habermann B (2003) Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 20:203–213PubMedCrossRef

11.

Thiery JP (2002) Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442–454PubMedCrossRef

12.

Thiery JP, Chopin D (1999) Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 18:31–42PubMedCrossRef

13.

Yang J, Mani SA, Donaher JL et al (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927–939PubMedCrossRef

14.

Kang Y, Massague J (2004) Epithelial–mesenchymal transitions: twist in development and metastasis. Cell 118:277–279PubMedCrossRef

15.

Kajiyama H, Kikkawa F, Maeda O et al (2002) Increased expression of dipeptidyl peptidase IV in human mesothelial cells by malignant ascites from ovarian carcinoma patients. Oncology 63:158–165PubMedCrossRef

16.

Kajiyama H, Kikkawa F, Khin E et al (2003) Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res 63:2278–2283PubMed

17.

Kajiyama H, Kikkawa F, Suzuki T et al (2002) Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma. Cancer Res 62:2753–2757PubMed

18.

Melchiori A, Mortarini R, Carlone S et al (1995) The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion. Exp Cell Res 219:233–242PubMedCrossRef

19.

Bartolazzi A, Cerboni C, Nicotra MR et al (1994) Transformation and tumor progression are frequently associated with expression of the alpha 3/beta 1 heterodimer in solid tumors. Int J Cancer 58:488–491PubMedCrossRef

20.

Van Waes C, Surh DM, Chen Z et al (1995) Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res 55:5434–5444PubMed

21.

Tawil NJ, Gowri V, Djoneidi M et al (1996) Integrin alpha3beta1 can promote adhesion and spreading of metastatic breast carcinoma cells on the lymph node stroma. Int J Cancer 66:703–710PubMedCrossRef

22.

Schumacher D, Schaumburg-Lever G (1996) Ultrastructural localization of alpha-3 integrin subunit in malignant melanoma and adjacent epidermis. J Cutan Pathol 26:321–326CrossRef

23.

Kishima H, Shimizu K, Tamura K et al (1999) Monoclonal antibody ONS-M21 recognizes integrin alpha3 in gliomas and medulloblastomas. Br J Cancer 79:333–339PubMed

24.

Kreidberg JA (2000) Functions of alpha3beta1 integrin. Curr Opin Cell Biol 12:548–553PubMedCrossRef

25.

Tsuji T, Kawada Y, Kai-Murozono M et al (2002) Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). Clin Exp Metastasis 19:127–134PubMedCrossRef

26.

Fukushima Y, Ohnishi T, Arita N et al (1998) Integrin alpha3beta1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. Int J Cancer 76:63–72PubMedCrossRef

27.

Hosono J, Narita T, Kimura N et al (1998) Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells. J Surg Oncol 67:77–84PubMedCrossRef

28.

Gangopadhyay A, Lazure DA, Thomas P et al (1998) Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis 16:703–712PubMedCrossRef

29.

Ziprin P, Ridgway PF, Pfistermuller KL et al (2003) ICAM-1 mediated tumor-mesothelial cell adhesion is modulated by IL-6 and TNF-alpha: a potential mechanism by which surgical trauma increases peritoneal metastases. Cell Commun Adhes 10:141–154PubMedCrossRef

30.

Khashayar L, Dean JA, Theodore O et al (1999) CD44 and β1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol 154:1525–1537

31.

Nelson AR, Fingleton B, Rothenberg ML et al (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135–1149PubMed

32.

Sier CF, Kubben FJ, Ganesh S et al (1996) Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 74:413–417PubMed

33.

Kuniyasu H, Troncoso P, Johnston D et al (2000) Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers. Clin Cancer Res 6:2295–2308PubMed

34.

Marti HP, McNeil L, Davies M et al (1993) Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells. Biochem J 291:441–446PubMed

35.

Marti HP, Lee L, Kashgarian M et al (1994) Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am J Pathol 144:82–94PubMed

36.

Pulyaeva H, Bueno J, Polette M et al (1997) MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 15:111–120PubMedCrossRef

37.

Wang H, Keiser JA (2000) Hepatocyte growth factor enhances MMP activity in human endothelial cells. Biochem Biophys Res Commun 272:900–905PubMedCrossRef

38.

Takahashi M, Tsunoda T, Seiki M et al (2002) Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene 21:5861–5867PubMedCrossRef

39.

Brabletz T, Jung A, Dag S et al (1999) Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155:1033–1038PubMed

40.

Crawford HC, Fingleton BM, Rudolph-Owen LA et al (1999) The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18:2883–2891PubMedCrossRef

41.

Crawford HC, Fingleton B, Gustavson MD et al (2001) The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors. Mol Cell Biol 21:1370–1383PubMedCrossRef

42.

Mann B, Gelos M, Siedow A et al (1999) Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96:1603–1608PubMedCrossRef

43.

Wielenga VJ, Smits R, Korinek V et al (1999) Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154:515–523PubMed

44.

He TC, Sparks AB, Rago C et al (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512PubMedCrossRef

45.

Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426PubMedCrossRef

46.

Roose J, Huls G, van Beest M et al (1999) Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285:1923–1926PubMedCrossRef

47.

Gradl D, Kuhl M, Wedlich D et al (1999) The Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Mol Cell Biol 19:5576–5587PubMed

48.

Vallin J, Thuret R, Giacomello E et al (2001) Cloning and characterization of three Xenopus slug promoters reveal direct regulation by Lef/beta-catenin signaling. J Biol Chem 276:30350–30358PubMedCrossRef

49.

Hlubek F, Jung A, Kotzor N et al (2001) Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res 61:8089–8093PubMed

50.

Polette M, Gilles C, Nawrocki-Raby B et al (2005) Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Cancer Res 65:7691–7698PubMed

Titel: Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma
verfasst von: Mikio Terauchi
Hiroaki Kajiyama
Mamoru Yamashita
Mikihiko Kato
Hirohisa Tsukamoto
Tomokazu Umezu
Satoyo Hosono
Eiko Yamamoto
Kiyosumi Shibata
Kazuhiko Ino
Akihiro Nawa
Tetsuro Nagasaka
Fumitaka Kikkawa
Publikationsdatum: 01.09.2007
Verlag: Kluwer Academic Publishers
Erschienen in: Clinical & Experimental Metastasis / Ausgabe 5/2007
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-007-9070-1

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma

Abstract

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2007

An improved method to study NK-independent mechanisms of MTLn3 breast cancer lung metastasis

Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling

Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value

MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2

Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis

Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie